Sitagliptin phosphate yog dipeptidyl peptidase Ⅳ (DDP-4) inhibitor chav kawm ntawm cov tshuaj tsim los ntawm lub tuam txhab German Merck thiab thawj zaug tau txais kev pom zoo los ntawm US Food and Drug Administration rau kev kho mob ntshav qab zib hom 2, yog ib qho tshuaj tiv thaiv kab mob tshiab, tuaj yeem txhim kho lub cev ntawm tus kheej. muaj peev xwm txo cov ntshav qabzib ntau ntau, thiab qhov tshwm sim ntawm incretin tshwm sim los ntawm inhibiting cov haujlwm ntawm cov enzyme no, suav nrog qib ntawm glucagon-zoo li peptide 1 thiab cov piam thaj-dependent insulinotropic peptide, yog li ua rau cov txiav ua kom cov insulin ntau lawm thiab nres cov piam thaj. ntau lawm hauv daim siab, thiab thaum kawg txo cov kev kho mob ntawm cov ntshav qabzib concentration.